Field Trip Health Ltd. Schedules First Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, August 17, 2021 at 8:30 am ET
August 10 2021 - 7:55AM
Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field
Trip"), a global leader in the development and delivery of
psychedelic therapies, announced today that it plans to release
financial results for its first fiscal quarter ended June 30, 2021,
after market close on Monday, August 16, 2021.
The Company will conduct a conference call and
webcast to review its results the following day, Tuesday, August 17
at 8:30 am ET. To access the call, please dial 1-877-407-9716 or
1-201-493-6779 and provide conference ID 13722164. A live webcast
of the conference call can be accessed via the Events and
Presentations section of the Field Trip Health Investor Relations
website or via the following link:
http://public.viavid.com/index.php?id=146109.
For those unable to attend the live call, a
telephonic replay will be available until Tuesday, August 31, 2021.
To access the replay of the call dial 1-844-512-2921 or
1-412-317-6671 and provide conference ID 13722164. An archived copy
of the webcast will be available on the Events and Presentations
section of the Field Trip Health Investor Relations website after
the conclusion of the call.
About Field Trip Health
Ltd.Field Trip is a global leader in the development and
delivery of psychedelic therapies. With our Field Trip Discovery
division leading the development of the next generation of
psychedelic molecules and conducting advanced research on
plant-based psychedelics and our Field Trip Health division
building centers for psychedelic therapies opening across North
America and Europe along with the digital and technological tools
that will enable massive scale, we help people in need with a
simple, evidence-based way to heal and heighten engagement with the
world.
Learn more at https://www.meetfieldtrip.com,
https://www.fieldtriphealth.com and
https://www.fieldtriphealth.nl.
Follow us on Twitter and Instagram:
@fieldtriphealth
To receive company updates about Field Trip and
to be added to the email distribution list please sign up here.
Cautionary Note Regarding Forward-Looking
Information.
This release includes forward-looking
information (within the meaning of Canadian securities laws and
within the meaning of the United States Private Securities
Litigation Reform Act of 1995) regarding Field Trip and its
business. Often but not always, forward-looking information can be
identified by the use of words such as "expect", "intends",
"anticipated", "believes" or variations (including negative
variations) of such words and phrases, or state that certain
actions, events or results "may", "could", "would" or "will" be
taken, occur or be achieved. Such statements are based on the
current expectations and views of future events of the management
of Field Trip, and are based on assumptions and subject to risks
and uncertainties. Although the management of Field Trip believes
that the assumptions underlying these statements are reasonable,
they may prove to be incorrect. The forward-looking events and
circumstances discussed in this release may not occur and could
differ materially as a result of known and unknown risk factors and
uncertainties affecting the companies, including the timing and
results of its research and development programs, approval of phase
1 human trials, if any, the risk that future clinical studies may
not proceed as expected or may produce unfavorable results, the
opening of additional clinics, the COVID-19 epidemic, the medical
clinic industry, market conditions, economic factors, management's
ability to manage and to operate the business and the equity
markets generally. Although Field Trip has attempted to identify
important factors that could cause actual actions, events or
results to differ materially from those described in
forward-looking statements, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. Accordingly, readers should not place undue
reliance on any forward-looking statements or information. No
forward-looking statement can be guaranteed. Except as required by
applicable securities laws, forward-looking statements speak only
as of the date on which they are made and Field Trip does not
undertake any obligation to publicly update or revise any
forward-looking statement, whether as a result of new information,
future events, or otherwise.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy securities.
Neither the Toronto Stock Exchange, nor its Regulation Services
Provider, have approved the contents of this release or accept
responsibility for the adequacy or accuracy of this release.
Media contacts:Rachel MoskowitzAutumn
Communications202-276-7881press@fieldtriphealth.com
Nick Opich / McKenna MillerKCSA Strategic
Communications212-896-1206 /
347-487-6197press@fieldtriphealth.com
Investor contacts:Elizabeth BarkerKCSA
Strategic Communications212-896-1203ebarker@kcsa.com
SOURCE Field Trip Health Ltd.
Field Trip Health (NASDAQ:FTRP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Field Trip Health (NASDAQ:FTRP)
Historical Stock Chart
From Apr 2023 to Apr 2024